Chemed (CHE) Stock Price

Chemed Price

NYSE·CLOSED
533.09USD-3.02 (-0.56 %)
Market closed

Revenue has compounded at 4.9% per year over the past 19 years to 2.53 B USD. Earnings per share have grown at 12.7% per year over the last 19 years. Chemed's net margin stands at 10.5%, down from 12.6% several years earlier. Chemed currently offers a dividend yield of about 0.41%. The payout ratio is around 12% of earnings. The dividend has grown at 12.4% per year over the past 19 years. Analysts set a median price target of 587.52 USD, implying 10.2% above the current price. Of 8 analysts, 6 rate the stock a buy — an overall Buy consensus. The stock trades about 45% above its 52-week low.

Chemed stock price

Volume
Ex-Dividend
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of Chemed over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Chemed stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Chemed's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Chemed Stock Price History
DateChemed Price
8/19/2026533.09 USD
8/18/2026536.11 USD
8/14/2026532.88 USD
8/13/2026537.17 USD
8/12/2026541.02 USD
8/11/2026537.14 USD
8/10/2026552.09 USD
8/7/2026552.72 USD
8/6/2026549.41 USD
8/5/2026538.74 USD
8/4/2026537.92 USD
8/3/2026540.57 USD
7/31/2026532.25 USD
7/30/2026534.79 USD
7/29/2026539.20 USD
7/27/2026512.52 USD
7/23/2026503.01 USD
7/22/2026503.52 USD
7/21/2026504.10 USD
7/20/2026513.68 USD
7/17/2026510.03 USD
7/16/2026501.51 USD
7/15/2026492.65 USD
7/14/2026491.89 USD
7/13/2026492.50 USD
7/10/2026488.59 USD
7/9/2026490.46 USD
7/8/2026484.98 USD
7/7/2026485.37 USD
7/6/2026482.77 USD
7/2/2026489.66 USD
7/1/2026480.87 USD
6/30/2026465.74 USD
6/29/2026458.54 USD
6/26/2026463.28 USD
6/25/2026453.15 USD
6/24/2026447.29 USD
6/23/2026444.11 USD
6/22/2026435.40 USD
6/18/2026437.73 USD
6/17/2026435.42 USD
6/16/2026428.21 USD
6/15/2026415.00 USD
6/12/2026418.77 USD
6/11/2026427.39 USD
6/10/2026439.47 USD
6/9/2026446.26 USD
6/8/2026439.13 USD
6/5/2026441.41 USD
6/4/2026433.56 USD
6/3/2026424.86 USD
6/2/2026420.25 USD
6/1/2026422.60 USD
5/29/2026441.70 USD
5/28/2026439.29 USD
5/27/2026439.76 USD
5/26/2026437.52 USD
5/22/2026439.55 USD
5/21/2026440.81 USD
5/20/2026439.01 USD
5/19/2026440.05 USD
5/18/2026441.62 USD
5/15/2026434.53 USD
5/14/2026426.21 USD
5/13/2026424.04 USD
5/12/2026419.65 USD
5/11/2026421.43 USD
5/8/2026424.26 USD
5/7/2026425.82 USD
5/6/2026424.56 USD
5/5/2026427.55 USD
5/4/2026425.92 USD
5/1/2026422.16 USD
4/30/2026424.98 USD
4/29/2026423.94 USD
4/28/2026421.10 USD
4/27/2026422.72 USD
4/24/2026421.11 USD
4/23/2026382.97 USD
4/22/2026373.15 USD
4/21/2026373.79 USD
4/20/2026385.77 USD
4/17/2026384.61 USD
4/16/2026382.88 USD
4/15/2026377.61 USD
4/14/2026376.41 USD
4/13/2026387.62 USD
4/10/2026385.84 USD
4/9/2026390.85 USD
4/8/2026395.25 USD
4/7/2026388.95 USD
4/6/2026386.36 USD
4/2/2026380.60 USD
4/1/2026377.57 USD
3/31/2026377.74 USD
3/30/2026374.09 USD
3/27/2026368.59 USD
3/26/2026371.95 USD
3/25/2026371.95 USD
3/24/2026374.02 USD
3/23/2026373.89 USD
3/22/2026373.42 USD
3/20/2026377.99 USD
3/19/2026377.99 USD
3/18/2026384.83 USD
3/17/2026383.21 USD
3/16/2026399.34 USD
3/15/2026398.33 USD
3/13/2026401.87 USD
3/12/2026401.87 USD
3/11/2026399.55 USD
3/10/2026402.72 USD
3/9/2026400.76 USD
3/8/2026403.47 USD
3/6/2026407.88 USD
3/5/2026407.88 USD
3/4/2026412.16 USD
3/3/2026410.99 USD
3/2/2026424.16 USD
3/1/2026421.40 USD
2/27/2026410.01 USD
2/26/2026410.01 USD
2/25/2026396.63 USD
2/24/2026466.60 USD
2/23/2026468.32 USD
2/22/2026478.54 USD
2/20/2026475.41 USD
2/19/2026475.41 USD
2/18/2026472.11 USD
2/17/2026467.65 USD
2/16/2026473.06 USD
2/13/2026473.22 USD
2/12/2026473.22 USD
2/11/2026463.95 USD
2/10/2026462.89 USD
2/9/2026452.00 USD
2/8/2026448.17 USD
2/6/2026447.74 USD
2/5/2026447.74 USD
2/4/2026453.40 USD
2/3/2026443.76 USD
2/2/2026433.11 USD
2/1/2026435.27 USD
1/30/2026427.14 USD
1/29/2026427.14 USD
1/28/2026430.00 USD
1/27/2026432.56 USD
1/26/2026436.72 USD
1/25/2026448.03 USD
1/23/2026446.77 USD
1/22/2026446.77 USD
1/21/2026444.74 USD
1/20/2026453.53 USD
1/19/2026449.59 USD
1/16/2026451.90 USD
1/15/2026451.90 USD
1/14/2026458.93 USD
1/13/2026451.82 USD
1/12/2026448.44 USD
1/11/2026446.15 USD
1/9/2026444.40 USD
1/8/2026444.40 USD
1/7/2026449.18 USD
1/6/2026439.28 USD
1/5/2026441.09 USD
1/4/2026437.97 USD
1/2/2026423.79 USD
1/1/2026423.79 USD
12/31/2025427.86 USD
12/30/2025427.86 USD
12/29/2025430.82 USD
12/28/2025434.43 USD
12/26/2025432.18 USD
12/25/2025432.18 USD
12/24/2025435.28 USD
12/23/2025435.28 USD
12/22/2025432.66 USD
12/21/2025435.74 USD
12/19/2025435.33 USD
12/18/2025435.33 USD
12/17/2025430.24 USD
12/16/2025431.24 USD
12/15/2025429.13 USD
12/14/2025430.44 USD
12/12/2025430.06 USD
12/11/2025430.06 USD
12/10/2025429.16 USD
12/9/2025425.44 USD
12/8/2025420.48 USD
12/7/2025412.50 USD
12/5/2025421.97 USD
12/4/2025421.97 USD
12/3/2025424.30 USD
12/2/2025430.83 USD
12/1/2025429.54 USD
11/30/2025437.73 USD
11/28/2025439.19 USD
11/27/2025439.19 USD
11/26/2025441.36 USD
11/25/2025441.36 USD
11/24/2025440.70 USD
11/23/2025436.43 USD
11/21/2025441.74 USD
11/20/2025441.74 USD
11/19/2025429.33 USD
11/18/2025429.80 USD
11/17/2025435.33 USD
11/16/2025432.38 USD
11/14/2025435.56 USD
11/13/2025435.56 USD
11/12/2025446.01 USD
11/11/2025447.55 USD
11/10/2025445.53 USD
11/9/2025435.99 USD
11/7/2025434.61 USD
11/6/2025434.61 USD
11/5/2025430.59 USD
11/4/2025439.00 USD
11/3/2025439.09 USD
11/2/2025440.68 USD
10/31/2025431.30 USD
10/30/2025431.30 USD
10/29/2025454.44 USD
10/28/2025465.54 USD
10/27/2025438.94 USD
10/26/2025436.78 USD
10/23/2025436.62 USD
10/22/2025435.39 USD
10/21/2025439.30 USD
10/20/2025441.00 USD
10/19/2025444.95 USD
10/16/2025440.56 USD
10/15/2025430.92 USD
10/14/2025436.29 USD
10/13/2025437.13 USD
10/12/2025429.66 USD
10/9/2025430.02 USD
10/8/2025431.41 USD
10/7/2025434.96 USD
10/6/2025436.08 USD
10/5/2025435.38 USD
10/2/2025443.49 USD
10/1/2025442.04 USD
9/30/2025440.64 USD
9/29/2025447.74 USD
9/28/2025452.13 USD
9/25/2025462.23 USD
9/24/2025450.46 USD
9/23/2025456.98 USD
9/22/2025453.90 USD
9/21/2025455.91 USD
9/18/2025452.25 USD
9/17/2025458.25 USD
9/16/2025457.36 USD
9/15/2025447.63 USD
9/14/2025442.24 USD
9/11/2025446.40 USD
9/10/2025457.89 USD
9/9/2025450.70 USD
9/8/2025462.75 USD
9/7/2025463.78 USD
9/4/2025465.63 USD
9/3/2025459.70 USD
9/2/2025459.63 USD
9/1/2025464.00 USD
8/28/2025457.95 USD
8/27/2025451.90 USD
8/26/2025455.33 USD
8/25/2025446.26 USD
8/24/2025456.00 USD
8/21/2025459.05 USD
Access this data via the Eulerpool API

Chemed Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
2.14 B USD
344.53 M USD
268.55 M USD
Jan 1, 2022
2.13 B USD
343.50 M USD
249.62 M USD
Jan 1, 2023
2.26 B USD
342.01 M USD
272.51 M USD
Jan 1, 2024
2.43 B USD
366.49 M USD
302.00 M USD
Jan 1, 2025
2.53 B USD
338.25 M USD
265.24 M USD
Jan 1, 2026 (e)
2.72 B USD
421.75 M USD
387.58 M USD
Jan 1, 2027 (e)
2.88 B USD
447.76 M USD
417.99 M USD
Jan 1, 2028 (e)
3.01 B USD
472.46 M USD
438.12 M USD

Chemed Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 21, 2026, 5:41 PM
 
REVENUEB USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
DIV.USD
DIV. GROWTH%
SHARESM
20132014201520162017201820192020202120222023202420252026e2027e2028e
1.411.461.541.581.671.781.942.082.142.132.262.432.532.722.883.01
-1.193.045.982.145.716.968.757.282.89-0.236.097.384.037.555.964.58
28.5928.9129.4929.2530.9731.1431.8433.7235.9535.8535.2535.1329.9729.9729.9729.97
404.00421.00455.00461.00516.00555.00617.00701.00769.00765.00798.00854.00758.00815.25863.80903.37
133.00168.00184.00178.00121.00243.00261.00391.00344.00343.00342.00366.00338.00421.00447.00472.00
9.4111.5411.9211.297.2613.6413.4718.8116.0816.0715.1115.0613.3615.4815.5115.66
77.0099.00110.00108.0098.00205.00219.00319.00268.00249.00272.00301.00265.00387.00417.00438.00
-13.4828.5711.11-1.82-9.26109.186.8345.66-15.99-7.099.2410.66-11.9646.047.755.04
0.760.840.921.001.081.161.241.321.401.481.561.802.202.532.813.11
11.7610.539.528.708.007.416.906.456.065.715.4115.3822.2215.0011.0710.68
17.9017.4717.3716.6016.7816.6716.5716.3515.5115.0515.2714.9913.9913.9913.9913.99
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Chemed generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Chemed retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Chemed's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Chemed has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Chemed's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Chemed stock margins

The Chemed margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Chemed. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Chemed.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
35.98 %
16.11 %
12.55 %
Jan 1, 2022
35.84 %
16.09 %
11.69 %
Jan 1, 2023
35.28 %
15.10 %
12.03 %
Jan 1, 2024
35.14 %
15.07 %
12.42 %
Jan 1, 2025
29.97 %
13.37 %
10.48 %
Jan 1, 2026 (e)
29.97 %
15.50 %
14.25 %
Jan 1, 2027 (e)
29.97 %
15.53 %
14.50 %
Jan 1, 2028 (e)
29.97 %
15.67 %
14.53 %

Chemed Stock Revenue, EBIT, Earnings per Share

The Chemed earnings per share therefore indicates how much revenue Chemed has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
137.90 USD
22.21 USD
17.31 USD
Jan 1, 2022
141.84 USD
22.82 USD
16.58 USD
Jan 1, 2023
148.29 USD
22.40 USD
17.85 USD
Jan 1, 2024
162.17 USD
24.45 USD
20.14 USD
Jan 1, 2025
180.79 USD
24.17 USD
18.95 USD
Jan 1, 2026 (e)
179.15 USD
30.14 USD
25.52 USD
Jan 1, 2027 (e)
189.82 USD
32.00 USD
27.53 USD
Jan 1, 2028 (e)
198.51 USD
33.76 USD
28.85 USD

Chemed business model & stock analysis

Chemed Corp is an American company headquartered in Cincinnati, Ohio. It was founded in 1970 and has since become a leading provider of healthcare services. The company operates in two main business segments: Roto-Rooter and VITAS Healthcare. Roto-Rooter offers a wide range of plumbing, drainage, and sewer services, while VITAS Healthcare provides hospice and palliative care services. Chemed Corp also offers various everyday use products. The company has received numerous awards and recognitions and has plans to expand its services to new areas and markets through organic growth and targeted acquisitions. Overall, Chemed Corp has a strong business model and a diverse range of products and services tailored to consumer needs worldwide.

Chemed SWOT Analysis

Strengths

Chemed Corp possesses several key strengths that contribute to its success:

  • Strong brand reputation
  • Diverse portfolio of services
  • Experienced and skilled workforce
  • High customer satisfaction

Weaknesses

Despite its strengths, Chemed Corp also faces certain weaknesses:

  • Dependence on a few major customers
  • Limited geographical reach
  • Reliance on regulatory approvals
  • Higher prices compared to competitors

Opportunities

Chemed Corp can explore several opportunities to further grow its business:

  • Expansion into new markets
  • Acquisition of complementary businesses
  • Increased demand for healthcare services
  • Technological advancements in the industry

Threats

Chemed Corp should also be aware of potential threats that may impact its operations:

  • Intense competition in the healthcare sector
  • Changes in government regulations
  • Economic downturns affecting consumer spending
  • Labor shortages and rising labor costs

Chemed Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Chemed Employees
Details
Date
Chemed Employees
Jan 1, 2018
- Employees
Jan 1, 2019
- Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees

Chemed Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Chemed historical P/E ratio, EBIT multiple, and P/S ratio

Chemed annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Chemed shares outstanding

The number of shares of Chemed was 13.99 M in 2025. This indicates how many shares Chemed is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
15.51 M Stocks
Jan 1, 2022
15.05 M Stocks
Jan 1, 2023
15.27 M Stocks
Jan 1, 2024
14.99 M Stocks
Jan 1, 2025
13.99 M Stocks
Jan 1, 2026 (e)
13.99 M Stocks
Jan 1, 2027 (e)
13.99 M Stocks
Jan 1, 2028 (e)
13.99 M Stocks

Chemed stock splits

In Chemed's history, there have been no stock splits.

Chemed Dividend History

37 years of dividend payments · 17 consecutive increases

YearAnnual DividendYoY ChangePayments
20261.90USDYTD
Feb 23, 20260.60USD 0.0%1/3
May 28, 20260.60USD 0.0%2/3
Aug 17, 20260.70USD 16.7%3/3
20252.20USD 22.2%
Feb 24, 20250.50USD 0.0%1/4
May 29, 20250.50USD 0.0%2/4
Aug 11, 20250.60USD 20.0%3/4
Nov 17, 20250.60USD 0.0%4/4
20241.80USD 15.4%
20231.56USD 5.4%
20221.48USD 5.7%
20211.40USD 6.1%
20201.32USD 6.5%
20191.24USD 6.9%
20181.16USD 7.4%
20171.08USD 8.0%

Chemed dividend history and estimates

In 2025, Chemed paid a dividend amounting to 2.20 USD. Dividend means that Chemed distributes a portion of its profits to its owners.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2021
1.40 USD
0.00 USD
Jan 1, 2022
1.48 USD
0.00 USD
Jan 1, 2023
1.56 USD
0.00 USD
Jan 1, 2024
1.80 USD
0.00 USD
Jan 1, 2025
2.20 USD
0.00 USD
Jan 1, 2026 (e)
1.90 USD
0.63 USD
Jan 1, 2027 (e)
0.00 USD
2.81 USD
Jan 1, 2028 (e)
0.00 USD
3.11 USD

Chemed dividend payout ratio

In 2025, Chemed had a payout ratio of 11.61%. The payout ratio indicates the percentage of the company's profits that Chemed distributes as dividends.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
8.09 %
Jan 1, 2022
8.92 %
Jan 1, 2023
8.74 %
Jan 1, 2024
8.94 %
Jan 1, 2025
11.61 %
Jan 1, 2026 (e)
9.93 %
Jan 1, 2027 (e)
10.19 %
Jan 1, 2028 (e)
10.77 %

Current Chemed forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
75.00 % (6)
Hold
25.00 % (2)
Sell
0.00 % (0)
12M Price Target
587.52
Last Price
534.88
Currency
USD
12M Return Potential
9.84 %
LTM Return
0 %

Chemed Analyst Rating Actions

DateFirmActionRatingReliability
7/31/2026
Oppenheimer
Oppenheimer
MaintainedOutperform61
7/30/2026
RBC Capital
RBC Capital
MaintainedSector Perform48
7/9/2026
B of A Securities
B of A Securities
MaintainedNeutral67
4/27/2026
RBC Capital
RBC Capital
MaintainedSector Perform48
2/27/2026
RBC Capital
RBC Capital
DowngradeOutperformSector Perform48
2/27/2026
Oppenheimer
Oppenheimer
MaintainedOutperform61
1/22/2026
Jefferies
Jefferies
DowngradeBuyHold57
11/10/2025
RBC Capital
RBC Capital
MaintainedOutperform48
9/10/2025
B of A Securities
B of A Securities
MaintainedBuy67
9/2/2025
Jefferies
Jefferies
UpgradeHoldBuy57

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

Chemed Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
7/28/20265.66USD-671.69 MUSD-2026 Q2
4/23/20265.36USD-656.32 MUSD-2026 Q1
2/25/20267.14USD-665.68 MUSD-2025 Q4
4/24/20245.50USD-594.46 MUSD-2024 Q1
2/21/20246.31USD-592.51 MUSD-2023 Q4
7/25/20235.02USD-556.76 MUSD-2023 Q2
4/24/20234.71USD-548.66 MUSD-2023 Q1
2/22/20235.37USD-554.80 MUSD-2022 Q4
10/31/20224.69USD-534.96 MUSD-2022 Q3
7/27/20224.82USD-546.14 MUSD-2022 Q2
...

EESG©

Eulerpool ESG Scorecard© for the Chemed stock

55/100
62
Environment
46
Social
57
Governance
E

Environment

20
Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Chemed shareholder structure

% Name
8.80212%
BLACKROCK, INC.
BLACKROCK, INC.
5.37139%
VANGUARD PORTFOLIO MANAGEMENT LLC
VANGUARD PORTFOLIO MANAGEMENT LLC
4.18853%
VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC
3.29901%
JPMORGAN CHASE & CO
JPMORGAN CHASE & CO
3.04340%
STATE STREET CORP
STATE STREET CORP
2.73681%
AQR CAPITAL MANAGEMENT LLC
AQR CAPITAL MANAGEMENT LLC
...

Chemed Beneficial Ownership Filings (SEC 13D/G)

Free Float
98.2%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
11.31%
The Vanguard Group - 23-1945930
The Vanguard Group - 23-1945930
SEC ↗
9.40%
(1) BlackRock, Inc.
(1) BlackRock, Inc.
SEC ↗
7.71%
Edward C. Johnson 3d
Edward C. Johnson 3d
SEC ↗
7.70%
Page 2 of 5 Pages
Page 2 of 5 Pages
SEC ↗
7.70%
The Governor and Company of the Bank of Ireland
The Governor and Company of the Bank of Ireland
SEC ↗
7.70%
Iridian Asset Management LLC
Iridian Asset Management LLC
SEC ↗
7.70%
BIAM (US) Inc.
BIAM (US) Inc.
SEC ↗
7.70%
BIAM Holdings
BIAM Holdings
SEC ↗
7.70%
BancIreland (US) Holdings, Inc.
BancIreland (US) Holdings, Inc.
SEC ↗
7.32%
BlackRock for purposes of Schedule 13G filings.
BlackRock for purposes of Schedule 13G filings.
SEC ↗

Chemed Executives and Management Board

14 members · avg. age 65 · 14 % women

KM

Mr. Kevin Mcnamara (71)

President, Chief Executive Officer, Director · since 1986

12.77 M USD

Management

NW

Mr. Nicholas Westfall (46)

Executive Vice President

5.14 M USD
MW

Mr. Michael Witzeman (54)

Chief Financial Officer, Vice President, Controller

3.49 M USD
SL

Mr. Spencer Lee (69)

Executive Vice President · since 1999

2.95 M USD
BJ

Mr. Brian Judkins (44)

Vice President, Chief Legal Officer, Secretary

2.63 M USD

Board of Directors

GW

Mr. George Walsh (79)

Independent Chairman of the Board

480,851.00 USD
PG

Mr. Patrick Grace (69)

Independent Director

313,773.00 USD
CH

Mr. Christopher Heaney (71)

Independent Director

284,273.00 USD
RD

Mr. Ron DeLyons (63)

Independent Director

281,773.00 USD
JM

Mr. John Mount (56)

Independent Director

281,773.00 USD
TR

Mr. Thomas Rice (74)

Independent Director

281,773.00 USD

Chemed Supply Chain

Frequently asked questions about Chemed

The business model of Chemed Corp focuses on providing end-of-life care services through its subsidiaries, VITAS Healthcare and Roto-Rooter. Chemed Corp operates in two segments: VITAS, which offers hospice services to patients with life-limiting illnesses, and Roto-Rooter, a leading provider of plumbing and drain cleaning services. VITAS prioritizes compassionate care, aiming to enhance quality of life for patients and support their families. Roto-Rooter, on the other hand, provides essential plumbing solutions, specializing in emergency repairs, maintenance, and installation services. Chemed Corp's business model emphasizes delivering high-quality and specialized services in the healthcare and plumbing sectors, positioning itself as a reliable and trusted provider.

Chemed Corp is primarily active in the healthcare and service industries.

The main competitors of Chemed Corp in the market include companies such as Amedisys Inc, Brookdale Senior Living Inc, and Encompass Health Corporation.

Chemed Corp is a renowned company with a rich history and compelling background. Established in 1970, Chemed Corp began as a provider of plumbing and drain cleaning services through its Roto-Rooter subsidiary. Over the years, it expanded its operations and diversified into healthcare services. Currently, Chemed Corp is a leading provider of hospice and palliative care services through its subsidiary, VITAS Healthcare. The corporation's commitment to exceptional patient care has earned it a stellar reputation in the healthcare industry. Chemed Corp continues to grow and flourish, upholding its core values and consistently delivering outstanding services to those in need.

Chemed Corp has achieved several significant milestones throughout its history. The company experienced strong growth and expanded its services, becoming a leader in the healthcare industry. Chemed Corp's subsidiary, VITAS Healthcare, has reached noteworthy achievements, including the provision of compassionate end-of-life care to thousands of patients and their families. Additionally, Chemed Corp successfully acquired and integrated various companies, enhancing its business portfolio and market presence. The company's commitment to innovation, quality care, and strategic acquisitions has contributed to its continued success and recognition within the industry.

Chemed Corp is primarily present in the United States.

Chemed Corp is a company known for exemplifying values of integrity, excellence, and innovation. With a strong corporate philosophy, Chemed prioritizes a customer-centric approach, constantly striving to meet and exceed their expectations. Their commitment to ethical practices and the highest standards in healthcare services distinguish them in the industry. Chemed also emphasizes the importance of fostering a positive work environment, valuing their employees and promoting professional growth. By consistently delivering exceptional results, Chemed reflects a dedication to long-term success and sustainable progress.

Analysts currently set an average price target of 566.61 USD for the Chemed stock (median: 587.52 USD), implying +5.9 % versus the latest price. The consensus is based on 8 analyst ratings.

8 analysts currently rate the Chemed stock: 6 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Chemed to generate revenue of 2.72 B USD and earnings per share of 27.70 USD.

Converted at the current exchange rate, the Chemed share trades at 456.34 EUR (533.09 USD).

The Chemed share (CHE) is listed on 2 stock exchanges, including: NYSE (CHE), Frankfurt (CXM.F).

Chemed Corp is a US-based company operating in the hospice and drain cleaning sectors. It was founded in 1970 and is headquartered in Cincinnati, Ohio. Hospice services: Chemed Corp is the parent company of Vitas Healthcare, one of the largest hospice providers in the US. Vitas Healthcare offers a wide range of services for patients with life-threatening illnesses, including home care, support for family members and caregivers, pain therapy, and emotional support. Vitas Healthcare has a nationwide network of hospice centers and is a preferred hospice provider for Medicare, Medicaid, and private insurance companies. The company has also built partnerships with hospitals and nursing facilities to provide its customers access to top-quality care. Drain cleaning services: Chemed Corp also operates Roto-Rooter, one of the leading drain cleaning and plumbing companies in North America. The company offers a wide range of services, including pipe cleaning, sewer rehabilitation, and inspections of residential and commercial areas. Roto-Rooter is available 24/7 and offers emergency services. The company has also built a network of franchisees offering their services in multiple countries worldwide. Other business areas: In addition, Chemed Corp also operates milk production management consulting through its subsidiary Agri-Best. The company provides consulting services for dairy farms and assists with diets and feeding plans for dairy cows, among other services. Products: Chemed Corp offers a wide range of products for the hospice and drain cleaning sectors. For example, Vitas Healthcare offers medical supply products for customers and their environments, including respiratory aids, medical devices, and infusion pumps. Roto-Rooter offers plumbing products such as drain cleaners and pipes. Summary: Chemed Corp is a company operating in the hospice and drain cleaning sectors. The company offers a wide range of services and operates subsidiaries such as Vitas Healthcare and Roto-Rooter. Chemed Corp is also active in other business areas such as dairy management. The company offers a variety of products relevant to its different business sectors.

The expected revenue of Chemed is 2.72 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Chemed is 387.58 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Chemed is currently 19.25. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Chemed stock.

The price-to-sales ratio (P/S) of Chemed is currently 2.74. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Chemed stock.

The Eulerpool Quality Score for Chemed is 6/10.

The ISIN of Chemed is US16359R1032. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Chemed is A0CBF4. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Chemed is CHE. The ticker symbol is used to trade Chemed shares on the stock exchange.

Over the past 12 months, Chemed paid a dividend of 2.20 USD . This corresponds to a dividend yield of about 0.41 %. For the coming 12 months, Chemed is expected to pay a dividend of 2.66 USD.

The current dividend yield of Chemed is 0.41 %.

Chemed pays a dividend, distributed in the months of , , , .

Chemed paid dividends every year for the past 36 years.

For the upcoming 12 months, dividends amounting to 2.66 USD are expected. This corresponds to a dividend yield of 0.50 %.

Chemed is assigned to the 'Health' sector.

To receive the latest dividend of Chemed from amounting to 0.6 USD, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Chemed distributed 1.8 USD as dividends.

The dividends of Chemed are distributed in USD.

All fundamentals and in-depth analysis of Chemed

Our stock analysis for Chemed stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Chemed. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.